10x Genomics, Inc.
TXG
$18.81
$0.060.32%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 58.19% | 64.72% | 40.58% | 28.41% | 18.27% |
| Total Depreciation and Amortization | -5.73% | -10.42% | -9.61% | 0.20% | 11.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.19% | -23.87% | -21.89% | -19.34% | -10.09% |
| Change in Net Operating Assets | -74.69% | -160.30% | 110.70% | -92.77% | 203.29% |
| Cash from Operations | 126.00% | 961.12% | 311.74% | 143.85% | 243.84% |
| Capital Expenditure | 47.63% | 58.83% | 75.77% | 74.50% | 84.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -205.64% | -173.74% | -147.50% | -111.11% | -74.12% |
| Cash from Investing | -297.21% | -243.04% | -286.84% | -124.44% | -63.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -24.41% | -46.90% | -48.20% | -43.98% | -36.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -24.41% | -46.90% | -48.20% | -20.16% | -8.02% |
| Foreign Exchange rate Adjustments | -5.49% | 711.86% | 98.10% | -396.97% | 29.08% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -58.58% | -63.47% | 33.11% | -111.53% | 13.98% |